Drug Type Small molecule drug |
Synonyms OCT 3598, OCT3598 |
Target |
Mechanism EP2 antagonists(Prostanoid EP2 receptor antagonists), EP4 antagonists(Prostanoid EP4 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization KANAPH Therapeutics, Inc.Startup |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | KR | 19 Dec 2023 | |
Solid tumor | Preclinical | KR | KANAPH Therapeutics, Inc.Startup | 19 Dec 2023 |